title: TLR4/CD14-mediated PI3K activation is an essential component of interferon-dependent VSV resistance in macrophages.
abstract: Phosphatidylinositol-3-phosphate kinase (PI3K) has been reported to exhibit anti-inflammatory roles as a negative modulator of the NF-kappaB pathway (MyD88- and Mal-dependent) triggered upon Toll-like receptor (TLR)4 activation by lipopolysaccharide (LPS). Here, we investigated the role of PI3K on the TLR4-dependent, MyD88-independent signaling cascade which is activated in macrophages infected by Vesicular Stomatitis Virus (VSV) and leads to interferon production, thus conferring antiviral protection. We show that VSV induces TLR4 (and CD14)-dependent Akt phosphorylation. We observed hypersusceptibility to viral infections after pharmacological inactivation of the PI3K pathway in macrophages, which indicates that normal PI3K functions are critical for type I interferon synthesis and viral resistance. Conversely, we noticed increased resistance in macrophages isolated from genetically modified mice in which the PI3K pathway is constitutively active. Our data, which demonstrate that PI3K-Akt axis is an important component of the TLR4-dependent antiviral mechanism, also indicate that pharmacological modulation of this pathway to regulate the inflammatory response could promote viral susceptibility.
authors.affiliation: Department for Vascular Biology, Center for Biomolecular Medicine and Pharmacology, Medical University Vienna, Schwarzspanierstrasse 17, Vienna, Austria.
authors.forename: Gernot
authors.initials: G
authors.lastname: Schabbauer
authors.forename: James
authors.initials: J
authors.lastname: Luyendyk
authors.forename: Karine
authors.initials: K
authors.lastname: Crozat
authors.forename: Zhengfan
authors.initials: Z
authors.lastname: Jiang
authors.forename: Nigel
authors.initials: N
authors.lastname: Mackman
authors.forename: Siamak
authors.initials: S
authors.lastname: Bahram
authors.forename: Philippe
authors.initials: P
authors.lastname: Georgel
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D002470:Cell Survival; D004789:Enzyme Activation; D007113:Immunity, Innate / Q000276:immunology; D007372:Interferons / Q000276:immunology*; D018950:Lipopolysaccharide Receptors / Q000276:immunology*; D008264:Macrophages / Q000166:cytology / Q000201:enzymology / Q000276:immunology / Q000821:virology*; D051379:Mice; D051059:PTEN Phosphohydrolase / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000276:immunology*; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D018353:Rhabdoviridae Infections / Q000276:immunology*; D051197:Toll-Like Receptor 4 / Q000276:immunology*; D018116:Vesiculovirus / Q000276:immunology*
chemical_list: D018950:Lipopolysaccharide Receptors; D051197:Toll-Like Receptor 4; D007372:Interferons; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse